Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now — JobsAI.
The Global Medical Affairs Director develops and implements strategic and operational Therapeutic Areas (TAs) Global Medical Affairs programs. Location: London, Barcelona, Basel (East Hanover). Role Type: Hybrid Working. Focused on innovative evidence and launch readiness along with post-market solutions, including medical affairs planning and execution of the medical/scientific engagement strategy. They address and deliver strategic pre-launch and launch medical activities needs for patient, clinical, access and value to health care systems. Providing expertise in the development and execution of the overarching strategies and providing inputs during design and along the end-to-end execution of programs. They also develop and execute the Integrated Evidence Plan (IEP)/functional specific programs to maximize the value proposition for the prioritized launch portfolio and impact of our medicines.
The Global Medical Affairs (GMA) team acts as enterprise medical voice across the asset lifecycle and leads the medical strategy for the TA. They develop/own IEP and provide input into development while ensuring US and International medical perspective is reflected.
Responsible for the implementation of medical strategies for early programs globally with focus on innovative evidence solutions including interventional studies, Non-interventional studies (NIS) and Real World Evidence (RWE) studies and implementation science projects. With extensive experience in drug development the Global Medical Affairs Director will be able to lead Integrated Evidence Packages in situations with higher scientific complexity and potential regulatory challenges. They will also manage the most complex assets and those that potentially will require deeper pharmacovigilance expertise.
Acting as a subject matter expert in the development of the overarching strategies, providing inputs during design and along the end-to-end execution of programs across different disease areas. They will provide leadership and deep medical expertise in the TA, pivoting support based on business priorities and will represent GMA with senior stakeholders.